Trial intelligence / Profile preview

REAL07: Lenalidomide plus R-CHOP21 for Elderly Patients With Untreated DLBCL

NCT00907348Phase 2Unknown

Sponsor
Fondazione Italiana Linfomi
Start
Oct 2007
Primary completion
Oct 2009
Countries
1
01

Overview

A Phase 2 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Fondazione Italiana Linfomi. Status: unknown.

02

Drugs

lenalidomide
03

Conditions

diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)

Beyond the preview

Go deeper on NCT00907348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00907348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call